Differential expression of Huntington's disease gene (IT15) mRNA in developing rat brain.

Huntington's disease (HD) is an autosomal dominant inheritance neurological disorder associated with CAG repeats expansions within a widely distributed gene that causes selective neuronal death. The gene is essential for normal development and has been suggested for its role in the development of basal ganglia. To understand its normal function during growth and development, we determined the expression patterns for the gene responsible for HD (IT15) mRNA by Northern blot analysis in the developing and adult rat brain. In adult rat brains, IT15 transcripts exist as two isoforms of 10 and 12.5 kb each, which display distinct expression patterns. IT15 mRNA expression is already highly expressed within 1 day of birth. Expression signals for IT15 were first detected at embryonic day 16 or 17 during prenatal development. IT15 transcript peaks leveled around day 20 postnatally and thereafter decreased to levels typically found in adults. In the adult rat brain, mRNA expression was highest in the cerebellum followed by the cortex, striatum, hippocampus and olfactory lobe. In the medulla and the spinal cord, IT15 was weakly expressed in comparison to the other regions studied. Thus, the distinct expression patterns provide a basis for its functional significance during development. These results also suggest that the degree of IT15 mRNA expression is related to the neuronal population in different brain regions.

[1]  Elena Cattaneo,et al.  Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.

[2]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[3]  S. Augood,et al.  Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellularin situ hybridization study , 1996, Neuroscience.

[4]  R. Roos,et al.  Characterization and localization of the Huntington disease gene product. , 1993, Human molecular genetics.

[5]  Joseph B. Martin,et al.  Somatostatin is increased in the basal ganglia in Huntington disease , 1983, Annals of neurology.

[6]  D. Surmeier,et al.  Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington’s Disease , 1999, The Journal of Neuroscience.

[7]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[8]  G. Bernhard Landwehrmeyer,et al.  IT15 gene expression in fetal human brain , 1994, Brain Research.

[9]  R. Durbin,et al.  Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat , 1994, Somatic cell and molecular genetics.

[10]  M. MacDonald,et al.  Mutant Huntingtin Forms in Vivo Complexes with Distinct Context-Dependent Conformations of the Polyglutamine Segment , 1999, Neurobiology of Disease.

[11]  P. Willems Dynamic mutations hit double figures , 1994, Nature Genetics.

[12]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[13]  A. Young,et al.  A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.

[14]  G. Bernardi,et al.  Huntingtin distribution among striatal output neurons of normal rat brain , 2003, Neuroscience Letters.

[15]  P. Emson,et al.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease , 1985, Brain Research.

[16]  S. Folstein Huntington's disease : a disorder of families , 1989 .

[17]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[18]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[19]  L. Farrer,et al.  Homozygote for Huntington disease. , 1989, American journal of human genetics.

[20]  R. Gibbs,et al.  Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. , 1993, Science.

[21]  C A Ross,et al.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.

[22]  R. Albin,et al.  Genetics and molecular biology of Huntington's disease , 1995, Trends in Neurosciences.

[23]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[24]  M. McInnis,et al.  Genes with triplet repeats: candidate mediators of neuropsychiatric disorders , 1993, Trends in Neurosciences.

[25]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[26]  J. Penney,et al.  Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis , 1995, Neuroscience.

[27]  O. Riess,et al.  Expression of the Huntington disease gene in rodents: cloning the rat homologue and evidence for downregulation in non-neuronal tissues during development. , 1995, Human molecular genetics.

[28]  Edwin Reyniers,et al.  A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.

[29]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[30]  S. Folstein,et al.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.

[31]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[32]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[33]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[34]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[35]  D. Housman,et al.  Molecular approaches to hereditary diseases of the nervous system: Huntington's disease as a paradigm. , 1991, Annual review of neuroscience.

[36]  C. L. Warner,et al.  Meiotic stability and genotype – phenotype correlation of the trinucleotide repeat in X–linked spinal and bulbar muscular atrophy , 1992, Nature Genetics.

[37]  R. Richards,et al.  Heritable unstable DNA sequences , 1992, Nature Genetics.

[38]  Peter S. Harper,et al.  Huntington's disease , 1991 .

[39]  G. Bernardi,et al.  Co‐localization of brain‐derived neurotrophic factor (BDNF) and wild‐type huntingtin in normal and quinolinic acid‐lesioned rat brain , 2003, The European journal of neuroscience.

[40]  Paul W Goldberg,et al.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. , 1994, The New England journal of medicine.

[41]  C. Ross,et al.  Expression of the Huntington's disease (IT15) protein product in HD patients. , 1995, Human molecular genetics.

[42]  P G Bhide,et al.  Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.

[43]  U. Kumar,et al.  Expression of NMDA Receptor-1 (NR1) and Huntingtin in Striatal Neurons Which Colocalize Somatostatin, Neuropeptide Y, and NADPH Diaphorase: A Double-Label Histochemical and Immunohistochemical Study , 1997, Experimental Neurology.

[44]  M. MacDonald,et al.  Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum , 1997, The Journal of Neuroscience.

[45]  J. Penney,et al.  Huntingtin localization in brains of normal and Huntington's disease patients , 1997, Annals of neurology.

[46]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[47]  Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade. , 1995 .

[48]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[49]  M. MacDonald,et al.  Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals , 1995, Annals of neurology.

[50]  J. Rommens,et al.  Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. , 1993, Human molecular genetics.

[51]  L. Surh,et al.  Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene , 1993, Nature Genetics.

[52]  Blair R. Leavitt,et al.  Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.

[53]  R. Albin,et al.  Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.